- Home
- MODD vs BEAT Comparison
MODD vs BEAT Comparison
Compare MODD & BEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MODD | BEAT |
|---|---|---|
| Founded | 1998 | 2015 |
| Country | United States | United States |
| Employees | N/A | 17 |
| Industry | Industrial Specialties | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 31.6M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | MODD | BEAT |
|---|---|---|
| Price | $2.03 | $0.49 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $5.63 |
| AVG Volume (30 Days) | 140.6K | ★ 581.0K |
| Earning Date | 02-17-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $315.97 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $0.48 |
| 52 Week High | $6.16 | $4.00 |
Technical Indicators
Market Signals| Indicator | MODD | BEAT |
|---|---|---|
| Relative Strength Index (RSI) | 31.53 | 34.10 |
| Support Level | $0.31 | N/A |
| Resistance Level | $5.76 | $0.79 |
| Average True Range (ATR) | 0.34 | 0.04 |
| MACD | -0.04 | 0.00 |
| Stochastic Oscillator | 6.06 | 8.86 |
Price Performance
Historical ComparisonAbout MODD Modular Medical Inc.
Modular Medical Inc is a development stage medical device company which focuses on the design, development, and commercialization of insulin pumps using modernized technology to increase pump adoption in the diabetes marketplace. The company's products seek to serve both the type 1 and the rapidly growing, especially in terms of device adoption, type 2 diabetes markets.
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.